MME and cardiac hypertrophy: NEP antagonists alone and in combination with ACE (angiotensin converting enzyme) and ECE (endothelin converting enzyme) inhibitors were able to improve cardiac function, limit cardiac hypertrophy, and decrease systemic blood pressure (252–255).